In the field of the genetics of rare diseases, exome analysis (i.e sequencing of all coding parts of the genome (about 23,000 genes)), is a widespread diagnostic tool. The data produced by these analyzes are heavy and it is difficult to extract the pathogenic variations implicated in the patient phenotype. This task is realized by geneticists (molecular biologists). To facilitate this step, bio-informaticians annotate these data with knowledge from various data sources chosen by geneticists. Geneticists therefore depend on bio-informaticians and are not free to simply test and experiment with new sources of knowledge. Each database added to the annotation process must be the subject of a development of dedicated scripts by the bio-informat...